Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4549410 | 0.89 | ALOX5 (0.33) | ALOX5 | |
| SCHEMBL12037561 | 0.86 | CASP3 (0.35) | — | |
| SCHEMBL4549409 | 0.85 | MAPK1 (0.32) | ALOX5 | |
| SCHEMBL12037563 | 0.85 | CASP3 (0.34) | — | |
| SCHEMBL12037564 | 0.84 | KDM4E (0.36) | — | |
| SCHEMBL4549432 | 0.84 | ALOX5 (0.44) | ALOX5 | |
| SCHEMBL8281495 | 0.84 | ALDH1A1 (0.36) | — | |
| SCHEMBL8281415 | 0.82 | HPGD (0.39) | — | |
| SCHEMBL788568 | 0.82 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL9604005 | 0.82 | NPC1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9406889-B2 | Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-08-02 | — | — | US | disclosed |
| US-9406889-B2 | Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-08-02 | — | — | US | disclosed |
| US-20150171333-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-18 | — | — | US | disclosed |
| US-20150171333-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-18 | — | — | US | disclosed |
| US-8968888-B2 | Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-03-03 | — | — | US | disclosed |
| US-8968888-B2 | Phenanthrene compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-03-03 | — | — | US | disclosed |
| US-20120104369-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-03 | — | — | US | disclosed |
| US-20120104369-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120104369-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | MC1R, NR2E3, RPS19 | ALOX5 3393/4885 |
| US-20150171333-A1 | Phenanthrene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | MC1R, NR2E3, RPS19 | ALOX5 3393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.